Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders

被引：0

|

作者：

C A Zarate

R Machado-Vieira

机构：

[1] Experimental Therapeutics and Pathophysiology Branch,

[2] Intramural Research Program,undefined

[3] National Institute of Mental Health,undefined

[4] National Institutes of Health,undefined

来源：

Molecular Psychiatry | 2017年 / 22卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：324 / 327

页数：3

相关论文

共 7 条

[1] Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
Zarate, C. A., Jr.
Machado-Vieira, R.
MOLECULAR PSYCHIATRY, 2017, 22 (03) : 324 - 327
[2] Glutamate modulators as novel interventions for mood disorders
Mathew, SJ
Keegan, K
Smith, L
REVISTA BRASILEIRA DE PSIQUIATRIA, 2005, 27 (03) : 243 - 248
[3] Is there a future for other glutamate receptor modulators in the pharmacotherapy of mood disorders?
Sos, Peter
EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (03) : 95 - 96
[4] Estrogen action in mood and neurodegenerative disorders: Estrogenic compounds with selective properties - The next generation of therapeutics
Österlund M.K.
Witt M.-R.
Gustafsson J.-Å.
Endocrine, 2005, 28 (3) : 235 - 241
[5] Next Generation Antidepressants. Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders
Walsh, Nicholas D.
PSYCHOLOGICAL MEDICINE, 2011, 41 (05) : 1109 - 1111
[6] The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
Maeng S.
Zarate Jr. C.A.
Current Psychiatry Reports, 2007, 9 (6) : 467 - 474
[7] A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
Wilkinson, Samuel T.
Sanacora, Gerard
DRUG DISCOVERY TODAY, 2019, 24 (02) : 606 - 615